The landscape of cancer treatment has been profoundly reshaped by the emergence of immunotherapy, a paradigm-shifting approach that harnesses the power of the body's own immune system to fight cancer. At the forefront of this revolution is pembrolizumab immunotherapy, marketed under the brand name Keytruda, and the broader class of PD-1 checkpoint inhibitors. These innovative...

The effectiveness of breast cancer chemotherapy depends not only on the active drug but also on the anticancer drug formulations that are used to deliver it. These formulations are designed to optimize drug stability, bioavailability, and safety, and to minimize side effects. The development of advanced anticancer drug formulations, such as liposomal and...

Market Overview The trifluridine tipiracil tablet market is experiencing growth as this combination chemotherapy demonstrates efficacy in advanced colorectal cancer and gastric cancer. The global market is projected to exceed USD 2.8 billion through 2030, driven by cancer prevalence, treatment-resistant disease management, and clinical trial expansion. Trifluridine tipiracil treats cancer...

According to the latest report published by Data Bridge Market Research, the Hodgkin Lymphoma Drug Market  CAGR Value The global Hodgkin Lymphoma Drug market size was valued at USD 3.50 billion in 2025 and is expected to reach USD 10.52 billion by 2033, at a CAGR of 14.75% during the forecast period This Hodgkin Lymphoma Drug Market research report has been formed with a...